Changes in Confidence, Feelings, and Perceived Necessity Concerning COVID-19 Booster.

Cheryl Lin, Brooke Bier, Ann M Reed, John J Paat, Pikuei Tu

Abstract read

In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed, 1 pooled it

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

COVID-19 Vaccination Messengers, Communication Channels, and Messages Trusted Among Black Communities in the USA: a Review.Journal of racial and ethnic health disparities · 2025
Pooled it
Temporal Dynamics of Vaccine Uptake: Perceptual and Social Drivers of Adoption Speed Across Innovation Diffusion Curve.Microorganisms · 2026
Article
Enhancing COVID-19 Vaccination Awareness and Uptake in the Post-PHEIC Era: A Narrative Review of Physician-Level and System-Level Strategies.Vaccines · 2024
Review
"Every Time It Comes Time for Another Shot, It's a Re-Evaluation": A Qualitative Study of Intent to Receive COVID-19 Boosters among Parents Who Were Hesitant Adopters of the COVID-19 Vaccine.Vaccines · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cheryl LinPolicy and Organizational Management Program, Duke University, Durham, NC 27708, USA.

Brooke BierPolicy and Organizational Management Program, Duke University, Durham, NC 27708, USA.

Ann M ReedSchool of Medicine, Duke University, Durham, NC 27708, USA.

John J PaatSchool of Medicine, Duke University, Durham, NC 27708, USA.

Pikuei TuPolicy and Organizational Management Program, Duke University, Durham, NC 27708, USA.

Funding

Duke University Bass Connections N/A

6 · The paper itself

Abstract

The COVID-19 booster first became available to all adults in the U.S. in November 2021 and a bivalent version in September 2022, but a large population remains booster-hesitant; only 17% of Americans have obtained the updated vaccine as of June 2023. We conducted two cross-sectional surveys in 2021 and 2022 (

Indexed as

attitudecommunicationhealth behaviorpandemicpublic healthrisk perceptionsTheory of Planned Behaviortrustvaccine hesitancyWheel of Emotions

Identifiers

PMID37515059

DOI10.3390/vaccines11071244

PMCPMC10383837

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.